Cipher Pharmaceuticals
(OTC) CPHRF
Cipher Pharmaceuticals Financials at a Glance
Market Cap
$303.20M
Revenue (TTM)
$50.64M
Net Income (TTM)
$27.53M
EPS (TTM)
$1.05
P/E Ratio
11.17
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Price
$11.99
Volume
11,350
Open
$12.10
Price
$11.99
Volume
11,350
Open
$12.10
Previous Close
$11.99
Daily Range
$11.99 - $12.17
52-Week Range
$6.63 - $12.70
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Price
$11.99
Volume
11,350
Open
$12.10
Previous Close
$11.99
Daily Range
$11.99 - $12.17
52-Week Range
$6.63 - $12.70
CPHRF News
CPHRF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cipher Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
9
CEO
Craig Mull
Website
www.cipherpharma.comHeadquarters
Mississauga, ON L6H 0M2, CA
CPHRF Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
33%
Net Income Margin
54%
Return on Equity
24%
Return on Capital
13%
Return on Assets
18%
Earnings Yield
8.95%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$303.20M
Shares Outstanding
25.28M
Volume
11.35K
Short Interest
0.00%
Avg. Volume
5.09K
Financials (TTM)
Gross Profit
$33.77M
Operating Income
$16.80M
EBITDA
$16.80M
Operating Cash Flow
$30.25M
Capital Expenditure
$28.49K
Free Cash Flow
$30.22M
Cash & ST Invst.
$7.48M
Total Debt
$5.49M
Cipher Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.41M
+4.9%
Gross Profit
$8.23M
+23.0%
Gross Margin
66.36%
N/A
Market Cap
$303.20M
N/A
Market Cap/Employee
$50.53M
N/A
Employees
6
N/A
Net Income
$13.52M
+304.2%
EBITDA
$4.27M
+155.3%
Quarterly Fundamentals
Net Cash
$1.98M
+108.7%
Accounts Receivable
$11.19M
-19.3%
Inventory
$8.18M
+41.1%
Long Term Debt
$5.21M
-87.1%
Short Term Debt
$288.47K
-49.0%
Return on Assets
17.63%
N/A
Return on Invested Capital
12.73%
N/A
Free Cash Flow
$8.84M
-0.4%
Operating Cash Flow
$8.87M
-0.2%